September 10, 2024

State of Alabama
Press Release: Medicaid

Preferred Drug List (PDL) and Pharmacy Quarterly Update

PDF Version

TO: Pharmacies, Physicians, Physician Assistants, Nurse Practitioners, Oral Surgeons, Optometrists, Dentists, FQHCs, RHCs, Mental Health Service Providers and Nursing Homes

 

RE:  Preferred Drug List (PDL) and Pharmacy Quarterly Update

 

Effective October 1, 2024, the Alabama Medicaid Agency (Medicaid) will:

 

1.  Continue to monitor the stimulant shortage affecting ADHD medications. Should you need assistance, please contact Acentra Health at the number below for alternative prescribing and dispensing options.

 

2.  Add the Asthma and Allergy Monoclonal Antibodies class to the PDL. Preferred products must meet clinical criteria to include FDA approved indications in order to be approved. Non-preferred products will require prior authorization (PA).

 

3.  Require PA for generic bepotastine besilate ophthalmic solution, and generic budesonide/formoterol fumarate inhalation, including Breyna. Brand Bepreve and brand Symbicort will remain preferred and will be billed with a Dispense as Written (DAW) Code of 9.  

   DAW Code of 9 indicates the following: Substitution Allowed by Prescriber but Plan Requests Brand. This value is used when the prescriber has indicated, in a manner specified by prevailing law, that generic substitution is permitted, but the Plan requests the brand product to be dispensed.

 

4.  Update the PDL to reflect the quarterly updates listed below:

PDL Additions

Fasenra CC

Asthma and Allergy Monoclonal Antibodies

Qvar RediHaler

Respiratory Corticosteroids

Tezspire CC

Asthma and Allergy Monoclonal Antibodies

Xolair CC

Asthma and Allergy Monoclonal Antibodies

PDL Deletions

bepotastine besilate ophthalmic solution

(generic Bepreve)

Eye, Ear, Nose and Throat Antiallergic Agents

Breyna and budesonide/formoterol fumarate inhalation

(generic Symbicort)

Respiratory Corticosteroids

            CC This agent will be preferred with clinical criteria in place.

 

For additional PDL and coverage information, visit our drug look-up site at

https://www.medicaid.alabamaservices.org/alportal/NDC%20Look%20Up/tabId/5/Default.aspx .

 

The PA request form and criteria booklet should be utilized by the prescriber or the dispensing pharmacy when requesting a PA. The PA request form can be completed and submitted electronically at https://medicaid.alabama.gov/content/9.0_Resources/9.4_Forms_Library/9.4.13_Pharmacy_Forms.aspx

 

Providers requesting PAs by mail or fax should send requests to:

 

Acentra Health

Medicaid Pharmacy Administrative Services

P.O. Box 3570, Auburn, AL 36831

Fax: 1-800-748-0116

Phone: 1-800-748-0130

 

Incomplete PA requests or those failing to meet Medicaid criteria will be denied. If the prescriber believes medical justification should be considered, the prescriber must document this on the form or submit a written letter of medical justification along with the PA form to Acentra Health. Additional information may be requested. Staff physicians will review this information.


The Current Procedural Terminology (CPT) and Current Dental Terminology (CDT) codes descriptors, and other data are copyright © 2021 American Medical Association
and © 20
21 American Dental Association (or such other date publication of CPT and CDT). All rights reserved. Applicable FARS/DFARS apply.




  • For more information, visit http://medicaid.alabama.gov
  • For more state-wide press releases, click here